SCHEMBL17065822

SCHEMBL17065822

COc1ccc2c(N3CCCCC3)c(Br)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42
CASP1 P29466 2/20 0.42
CASP7 P55210 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
TP53 P04637 1/20 0.42
PABPC1 P11940 1/20 0.42
APEX1 P27695 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.42
DYRK1A Q13627 2/20 0.41
MAPT P10636 2/20 0.40
RUNX1 Q01196 1/20 0.40
CBFB Q13951 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17065809 0.86 KDM4E (0.50) L3MBTL1MEN1KMT2AKDM4EALDH1A1
SCHEMBL17065833 0.73 HPGD (0.44) L3MBTL1MEN1KMT2AKDM4EMAPK1
SCHEMBL5752191 0.72 CYP2A6 (0.48) MEN1KMT2AKDM4ERAB9AMAPT
SCHEMBL15266968 0.72 CYP1A2 (0.48) MEN1KMT2AKDM4EDYRK1AMAPT
SCHEMBL5337507 0.70 TUBB4A (0.50) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL27902298 0.70 CYP2A6 (0.65) MEN1KMT2AKDM4EALDH1A1MAPK1
SCHEMBL6959555 0.69 KDM4E (0.56) L3MBTL1MEN1KMT2AKDM4EALDH1A1
SCHEMBL17065823 0.69 NPSR1 (0.44) ACHEL3MBTL1MEN1KMT2AKDM4E
SCHEMBL11786558 0.69 DYRK1A (0.55) ACHEMEN1KMT2AKDM4EALDH1A1
SCHEMBL3137389 0.68 CYP2A6 (0.62) MEN1KMT2AKDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed